» Articles » PMID: 23458909

Using Temporal Mining to Examine the Development of Lymphedema in Breast Cancer Survivors

Overview
Journal Nurs Res
Specialty Nursing
Date 2013 Mar 6
PMID 23458909
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Secondary lymphedema is a lifetime risk for breast cancer survivors and can severely affect quality of life. Early detection and treatment are crucial for successful lymphedema management. Limb volume measurements can be utilized not only to diagnose lymphedema but also to track progression of limb volume changes before lymphedema, which has the potential to provide insight into the development of this condition.

Objectives: This study aims to identify commonly occurring patterns in limb volume changes in breast cancer survivors before the development of lymphedema and to determine if there were differences in these patterns between certain patient subgroups. Furthermore, pattern differences were studied between patients who developed lymphedema quickly and those whose onset was delayed.

Methods: A temporal data mining technique was used to identify and compare common patterns in limb volume measurements in patient subgroups of study participants (n = 232). Patterns were filtered initially by support and confidence values, and then t tests were used to determine statistical significance of the remaining patterns.

Results: Higher body mass index and the presence of postoperative swelling are supported as risk factors for lymphedema. In addition, a difference in trajectory to the lymphedema state was observed.

Discussion: The results have potential to guide clinical guidelines for assessment of latent and early-onset lymphedema.

Citing Articles

Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema.

Mehrara B, Park H, Kataru R, Bromberg J, Coriddi M, Baik J Biology (Basel). 2021; 10(9).

PMID: 34571811 PMC: 8466465. DOI: 10.3390/biology10090934.


Lymphoedema After Breast Cancer Treatment is Associated With Higher Body Mass Index: A Systematic Review and Meta-Analysis.

Manirakiza A, Irakoze L, Shui L, Manirakiza S, Ngendahayo L East Afr Health Res J. 2021; 3(2):178-192.

PMID: 34308212 PMC: 8279288. DOI: 10.24248/EAHRJ-D-19-00009.


Differences in limb volume trajectories after breast cancer treatment.

Smoot B, Cooper B, Conley Y, Kober K, Levine J, Mastick J J Cancer Surviv. 2015; 10(4):772-82.

PMID: 26678895 PMC: 4912957. DOI: 10.1007/s11764-015-0507-2.

References
1.
Mahamaneerat W, Shyu C, Stewart B, Armer J . Breast cancer treatment, BMI, post-op swelling/lymphoedema. J Lymphoedema. 2011; 3(2):38-44. PMC: 2908324. View

2.
Lawenda B, Mondry T, Johnstone P . Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009; 59(1):8-24. DOI: 10.3322/caac.20001. View

3.
Armer J . The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005; 23(1):76-83. View

4.
Helyer L, Varnic M, Le L, Leong W, McCready D . Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J. 2009; 16(1):48-54. DOI: 10.1111/j.1524-4741.2009.00855.x. View

5.
Armer J, Stewart B, Shook R . 30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA. J Lymphoedema. 2010; 4(1):14-18. PMC: 2826842. View